Literature DB >> 2360723

The cerebral functional, metabolic, and hemodynamic effects of desflurane in dogs.

L J Lutz1, J H Milde, L N Milde.   

Abstract

The effects of 0.5-2.0 MAC (3.6-15%) desflurane on cerebral function, metabolism, and hemodynamics and on systemic metabolism and hemodynamics were examined in dogs. Desflurane produced a significant dose-related decrease in cerebral vascular resistance from 1.53 +/- 0.21 mmHg.ml-1.min.100 g at 0.5 MAC to 0.50 +/- 0.03 mmHg.ml-1.min.100 g at 2.0 MAC desflurane. This was accompanied by an increase in cerebral blood flow (CBF) from 61 +/- 7 ml.min-1.100 g-1 at 0.5 MAC to 78 +/- 3 ml.min-1.100 g-1 at 1.5 MAC desflurane. At 2.0 MAC desflurane CBF was 52 +/- 2 ml.min-1.100 g-1 but was associated with a decrease in mean arterial pressure (MAP) to 43 +/- 2 mmHg. When MAP was increased to 73 +/- 3 mmHg with phenylephrine, CBF increased to 87 +/- 3 ml.min-1.100 g-1 at this concentration. At 0.5 MAC desflurane, intracranial pressure (ICP) was 15 +/- 5 mmHg, higher than normal, but did not change significantly with increasing concentrations of desflurane. Increasing concentrations of desflurane initially produced on the EEG the common pattern sequence of increasing depth of anesthesia with decreasing frequency and increasing amplitude progressing to burst suppression and then at 2.0 MAC desflurane to regular attenuation with interruption by periodic polyspiking, a pattern similar to that seen with isoflurane. At both 1.5 and 2.0 MAC the EEG pattern initially observed at that concentration changed to one with faster background activity with time.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360723     DOI: 10.1097/00000542-199007000-00018

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

1.  Investigation of optical neuro-monitoring technique for detection of maintenance and emergence states during general anesthesia.

Authors:  Gabriela Hernandez-Meza; Meltem Izzetoglu; Mary Osbakken; Michael Green; Hawa Abubakar; Kurtulus Izzetoglu
Journal:  J Clin Monit Comput       Date:  2017-02-18       Impact factor: 2.502

Review 2.  Comparative tolerability profiles of the inhaled anaesthetics.

Authors:  J P Fee; G H Thompson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

3.  Effect of Isoflurane Anesthesia on Circadian Metabolism and Physiology in Rats.

Authors:  Melissa A Wren-Dail; Robert T Dauchy; David E Blask; Steven M Hill; Tara G Ooms; Lynell M Dupepe; Rudolf P Bohm
Journal:  Comp Med       Date:  2017-03-01       Impact factor: 0.982

4.  Tolerance to isoflurane does not occur in developing Xenopus laevis tadpoles.

Authors:  Pavle S Milutinovic; Jing Zhao; James M Sonner
Journal:  Anesth Analg       Date:  2009-01       Impact factor: 5.108

5.  Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs.

Authors:  J C Hartman; P S Pagel; L T Proctor; J P Kampine; W T Schmeling; D C Warltier
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

Review 6.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 7.  Desflurane clinical pharmacokinetics and pharmacodynamics.

Authors:  J E Caldwell
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

8.  Comparison of regional cerebral oxygen saturation during one-lung ventilation under desflurane or propofol anesthesia: A randomized trial.

Authors:  Keishu Hayashi; Yuko Yamada; Takuma Ishihara; Kumiko Tanabe; Hiroki Iida
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

Review 9.  The clinical use of desflurane.

Authors:  E I Eger
Journal:  Yale J Biol Med       Date:  1993 Sep-Oct
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.